NASDAQ: TARS · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

Tarsus Pharmaceuticals Inc.

How Tarsus Pharmaceuticals Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$3.7B

Price

$74.20

P/E

-69.1

EPS (TTM)

$-1.07

1-year return

9.9%

Dividend yield

0.0%

52-week range

$68.07–$78.61

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources